Innovative Nasal Spray Influenza Vaccine from DIFF Biotech Gains Approval for Clinical Trials#China#Hangzhou#Influenza_vaccine#DIFF_Biotech#DIFF-flu
Innovative Nasal Spray Influenza Vaccine from DIFF Biotech Gains Approval for Clinical Trials
DIFF Biotech's nasal spray influenza vaccine, DIFF-flu, has received approval for clinical trials in China, showcasing new safety features and innovation.
third-news.com
February 9, 2026 at 1:18 PM
Innovative Nasal Spray Influenza Vaccine from DIFF Biotech Gains Approval for Clinical Trials#China#Hangzhou#Influenza_vaccine#DIFF_Biotech#DIFF-flu